Table 2.

COVID‐19 vaccine development in the UK

University	Vaccine	Stage of development	Example clinical trials with the same vaccine platform
University of Oxford	ChAdOx1 nCoV‐19	Clinical trial recruitment	MERS, influenza, tuberculosis 28 , 29 , 62 Chikungunya (clinicaltrials.gov NCT03590392), Zika (clinicaltrials.gov NCT04015648)
Imperial College, London	Self‐amplifying RNA	Pre‐clinical	MTP‐CEPBA (clinicaltrials.gov NCT02716012, NCT04105335)
University of Cambridge	DNA	Pre‐clinical	N/A
Bristol University	Virus‐like particle	Pre‐clinical	N/A

This table outlines UK universities developing COVID‐19 vaccines, the vaccine platform under development, the stage of development for each vaccine, and examples of previous or ongoing clinical trials for this vaccine platform co‐ordinated by the university.